Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4300
-0.0491 (-10.25%)
At close: Jun 27, 2025, 4:00 PM
0.4500
+0.0200 (4.65%)
After-hours: Jun 27, 2025, 5:56 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,968,602
Market Cap
10.10M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4 | 0 | - |
Dec 31, 2023 | 4 | 0 | - |
Dec 31, 2022 | 4 | 1 | 33.33% |
Dec 31, 2021 | 3 | 0 | - |
Dec 31, 2020 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACXP News
- 9 days ago - Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds - PRNewsWire
- 10 days ago - Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI - PRNewsWire
- 18 days ago - Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference - PRNewsWire
- 6 weeks ago - Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - PRNewsWire
- 2 months ago - Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - PRNewsWire